Preventing drinking relapse in patients with alcoholic liver disease
Your role is essential in preventing, detecting, and co-managing alcoholic liver disease in inpatient and ambulatory settings
Related Resources
• Khan A, Tansel A, White DL, et al. Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review [published online August 6, 2015]. Clin Gastroenterol Hepatol. doi: 10.1016/j.cgh.2015.07.047.
• Vuittonet CL, Halse M, Leggio L, et al. Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health Syst Pharm. 2014;71(15):1265-1276.
Drug Brand Names
Acamprosate • Campral
Baclofen • Lioresal
Disulfiram • Antabuse
Gabapentin • Neurontin
Naltrexone • ReVia, Vivitrol
Pentoxifylline • Trental
Prednisolone • Prelone
Rifaximin • Xifaxan
Topiramate • Topamax
Disclosures
Dr. Winder and Dr. Mellinger report no financial relationships with any company whose products are mentioned in this article or with manufacturers of competing products. Dr. Fontana receives research funding from Bristol Myers Squibb, Gilead, and Janssen and consults for the Chronic Liver Disease Foundation.
